Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stenzl

Showing results (611-620 of 926) with videos related to

Pageof 93
Sort By:
Disease Markers|December 31, 2019
Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate CancerGiorgio Ivan Russo, Jörg Hennenlotter, Ulrich Vogel, et al.
World Journal of Urology|August 10, 2006
Tissue microarrays: applications in urological cancer researchA S Merseburger, A G Anastasiadis, J Hennenlotter, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 27, 2016
Laparoscopic radical nephrectomy with inferior vena cava thrombectomy: highlight of key surgical stepsA Sim, T Todenhöfer, J Mischinger, et al.
World Journal of Urology|September 20, 2011
Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?M Horstmann, L M Geiger, U Vogel, et al.
European Urology|August 3, 2013
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literatureMichael Rink, Marko Babjuk, James W F Catto, et al.
European Journal of Radiology|March 16, 2010
Tumorsize dependent detection rate of endorectal MRI of prostate cancer--a histopathologic correlation with whole-mount sections in 70 patients with prostate cancerMatthias C Roethke, Matthias P Lichy, Leo Jurgschat, et al.
International Journal of Molecular Sciences|March 29, 2023
Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and MetastasesMoritz Maas, Aymone Kurcz, Jörg Hennenlotter, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2025
Impact of sociodemographic and socioeconomic factors on functional and health-related quality of life outcomes 24 months after radical prostatectomyM Maas, K Funk, V Stühler, et al.
World Journal of Urology|May 26, 2007
The rationale for radical cystectomy as primary therapy for T4 bladder cancerUdo Nagele, Aristotelis G Anastasiadis, Axel S Merseburger, et al.
Lancet (London, England)|September 29, 2022
Current best practice for bladder cancer: a narrative review of diagnostics and treatmentsEva Compérat, Mahul B Amin, Richard Cathomas, et al.
Pageof 93

Showing results (611-620 of 926) with videos related to

Sort By:
Pageof 93
Disease Markers|December 31, 2019
Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate CancerGiorgio Ivan Russo, Jörg Hennenlotter, Ulrich Vogel, et al.
World Journal of Urology|August 10, 2006
Tissue microarrays: applications in urological cancer researchA S Merseburger, A G Anastasiadis, J Hennenlotter, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|August 27, 2016
Laparoscopic radical nephrectomy with inferior vena cava thrombectomy: highlight of key surgical stepsA Sim, T Todenhöfer, J Mischinger, et al.
World Journal of Urology|September 20, 2011
Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?M Horstmann, L M Geiger, U Vogel, et al.
European Urology|August 3, 2013
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literatureMichael Rink, Marko Babjuk, James W F Catto, et al.
European Journal of Radiology|March 16, 2010
Tumorsize dependent detection rate of endorectal MRI of prostate cancer--a histopathologic correlation with whole-mount sections in 70 patients with prostate cancerMatthias C Roethke, Matthias P Lichy, Leo Jurgschat, et al.
International Journal of Molecular Sciences|March 29, 2023
Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and MetastasesMoritz Maas, Aymone Kurcz, Jörg Hennenlotter, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2025
Impact of sociodemographic and socioeconomic factors on functional and health-related quality of life outcomes 24 months after radical prostatectomyM Maas, K Funk, V Stühler, et al.
World Journal of Urology|May 26, 2007
The rationale for radical cystectomy as primary therapy for T4 bladder cancerUdo Nagele, Aristotelis G Anastasiadis, Axel S Merseburger, et al.
Lancet (London, England)|September 29, 2022
Current best practice for bladder cancer: a narrative review of diagnostics and treatmentsEva Compérat, Mahul B Amin, Richard Cathomas, et al.
Pageof 93